Amylin Pharmaceuticals (AMLN) Reports Q1 Loss of 24c, Misses by 1c
Tweet Send to a FriendGet Alerts AMLN Hot Sheet
Price: $30.98 --0%
EPS Growth %: +4.2%
Financial Fact:
Interest and other expense, net: -44.71M
Today's EPS Names:
LBIX, ESEA, ISS, More
EPS Growth %: +4.2%
Financial Fact:
Interest and other expense, net: -44.71M
Today's EPS Names:
LBIX, ESEA, ISS, More
Trade AMLN Now!
Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) reported Q1 EPS of ($0.24), $0.01 worse than the analyst estimate of ($0.23). Revenue for the quarter came in at $152.7 million versus the consensus estimate of $156.73 million.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- J.C. Penney Co., Inc. (JCP) Posts Q1 Loss of $1.31/Share; Comps Down 16.6%
- iSoftStone Holdings (ISS) Tops Q1 EPS by 1c; Guides Q2, FY13
- Macy's (M) Posts Q1 EPS of 55c; Comps Up 3.8%; Boosts Dividend 25%, Raises Buyback
Create E-mail Alert Related Categories
Earnings, Hot Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
